New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- Peroral cholangioscopy by SpyGlass DS versus CHF-B260 for evaluation of the late
- 1
- 5 years, 8 months ago
- Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocki
- 1
- 5 years, 8 months ago
- Mismatch repair deficiency is a rare but putative therapeutically relevant findi
- 1
- 5 years, 8 months ago
- Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinom
- 1
- 5 years, 8 months ago
- Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholang
- 1
- 5 years, 8 months ago
- Antibody drug conjugates under investigation in phase I and phase II clinical tr
- 1
- 5 years, 8 months ago
- Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
- 1
- 5 years, 9 months ago
- EVI1 expression is associated with aggressive behavior in intrahepatic cholangio
- 1
- 5 years, 9 months ago
- The HER3 pathway as a potential target for inhibition in patients with biliary t
- 1
- 5 years, 9 months ago
- Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systemati
- 1
- 5 years, 9 months ago
- Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma an
- 1
- 5 years, 9 months ago
- MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transi
- 1
- 5 years, 9 months ago
- The forum ‘New Developments’ is closed to new topics and replies.